Related Experiment Video
Updated: Jul 23, 2026

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections
Published on: August 11, 2012
Chlamydia pneumoniae, the Heart, and Coronary Artery Disease: Is There a Cause and Effect Relationship?
1Division of Infectious Diseases, MCP Hahnemann University, 3300 Henry Avenue, Philadelphia, PA 19129, USA.
Insights
Chlamydia pneumoniae infection may contribute to atherosclerosis, though direct proof is lacking. Research reviews seroepidemiologic, histopathologic, and animal studies, plus antibiotic use impacts on cardiovascular outcomes.
Area of Science:
- Cardiovascular Research
- Infectious Disease Epidemiology
Background:
- Atherosclerosis is a complex disease with multiple contributing factors.
- The role of Chlamydia pneumoniae infection in atherosclerosis pathogenesis is under investigation.
Purpose of the Study:
- To review current evidence on the association between Chlamydia pneumoniae and atherosclerosis.
- To highlight recent findings from seroepidemiologic, histopathologic, and animal studies.
- To detail studies on antichlamydial antibiotic use and cardiovascular outcomes.
Main Methods:
- Review of seroepidemiologic data.
- Analysis of histopathologic findings.
- Examination of animal models of infection and atherosclerosis.
- Evaluation of studies on antibiotic interventions.
Main Results:
- Indirect evidence suggests a link between Chlamydia pneumoniae and atherosclerosis.
- Animal models provide insights into potential mechanisms.
- Studies on antibiotic use offer further clues regarding the association.
Conclusions:
- A definitive causal link between Chlamydia pneumoniae and atherosclerosis remains unproven.
- Ongoing research continues to explore this complex relationship.
- Further investigation is warranted to clarify the role of this infection in cardiovascular disease.
Abstract:
The possibility that infection with Chlamydia pneumoniae may somehow contribute to the pathogenesis of atherosclerosis continues to be explored by researchers worldwide. A direct cause-and-effect relationship between the bacterium and subsequent development of atherosclerosis has yet to be proved. However, compelling indirect evidence continues to mount in favor of this association. In this article the most recent information on this topic is reviewed. Seroepidemiologic and histopathologic evidence will be highlighted, as well as recent animal models of infection and atherosclerosis. In addition, current studies looking at the association of antichlamydial antibiotic use and risk of adverse cardiovascular outcomes will be detailed.
More Related Videos
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
08:25Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
Published on: April 7, 2015
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Bacterial Phylum Chlamydiae
Atypical Pneumonia
Pneumonia I: Introduction